No Data
Watching Hims & Hers Health; Traders Circulate Popular Retail Trading Newsletter Saying Stock Is Poised For A Major Surge In 2025
HIMS Downgraded, Agilon Upgraded at Citi in 2025 Health Tech Review
Citi Downgrades Hims & Hers Health(HIMS.US) to Sell Rating, Raises Target Price to $25
What's Going On With Hims & Hers Health Stock?
Wall Street's Riskiest Stocks Are Melting Down as Retail Traders Face 'Day of Reckoning'
Unusual Options Activity: IVZ, HIMS and Others Attract Market Bets, IVZ V/OI Ratio Reaches 198.8
EST Jan 8th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.